Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
IM
Immunic, Inc. Common Stock
IMUX
Mkt Cap
$94.5M
Volume
342.00K
Next Earnings
November 12th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
IM
IMUX
IM
Immunic, Inc. Common Stock
IMUX
News
·
Celiac Disease Market Report 2025-2035: Drivers, Challenges, Opportunities, Industry Trends and Case Studies
Mkt Cap
$95.1M
Volume
342.00K
Next Earnings
November 12th
Chart
Financials
Earnings
News
About
Insider
Filings
Celiac Disease Market Report 2025-2035: Drivers, Challenges, Opportunities, Industry Trends and Case Studies
The global celiac disease market is experiencing significant growth driven by rising awareness of gluten-related disorders, improved diagnostic technologies, and expanding gluten-free product offerings. Key drivers include increased prevalence, advancements in diagnostics, and emerging pharmacological therapies. However, challenges such as high costs of gluten-free products, limited availability in developing regions, and lack of definitive cures constrain market expansion. Major pharmaceutical companies are investing heavily in R&D for novel treatments and personalized medicine approaches.
GlobeNewswire Inc. · Dec 30, 2025
Immunic And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. OPKO Health The Trade: OPKO Health, Inc. (NASDAQ: OPK) 10% owner Frost Gamma Investments Trust acquired a total of 500,000 shares an average price of ...
Benzinga · Feb 29, 2024
Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday. SMX (Security Matters) Public Limited Company (NASDAQ: SMX) shares climbed 87.1% to $3.18 after the company announced it secured a majority stake in True Gold Consortium. PowerFleet, Inc. (NASDAQ: PWFL) gained 42% to $2.80. Powerfleet and MiX Telematics entered into a definitive agreement to form one of the largest mobile asset Internet of Things Software-as-a-Service providers in the world. SaverOne 2014 Ltd (NASDAQ: SVRE) rose 31.1% to $0.7010. Intrusion Inc. (NASDAQ: INTZ) gained 30.4% to $0.4565. Intrusion has been awarded a $5 million agreement with a large telecommunications provider to provide Intrusion Shield support for its data centers. Startek, Inc. (NYSE: SRT) gained 29.1% to $4.21 as the company agreed to be acquired by funds managed by CSP Management Limited for $4.30 per share in cash. CISO Global Inc. (NASDAQ: CISO) shares climbed 29.1% to $0.18. CISO Global said its Argo Edge Cloud Security Platform has been independently valued at $49 million. Mobilicom Limited (NASDAQ: MOB) climbed 27.1% to $1.8050, after gaining more than 11% on Monday. PGT Innovations, Inc. (NYSE: PGTI) surged 21.8% to $31.92. NanoString Technologies, Inc. (NASDAQ: NSTG) gained 20.7% to $1.4506 after the company disclosed third-quarter preliminary results and a reorganization designed to accelerate its path to profitability. Erasca, Inc. (NASDAQ: ERAS) rose 20.6% to $2.6550. Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) climbed 19% to $0.2209. MDxHealth SA (NASDAQ: MDXH) gained 18.5% to $2.82. MDxHealth reported preliminary revenues of $19.3 million for the third quarter, representing an increase of 73% year over year. Lexicon Pharmaceuticals, Inc. (NASDAQ:
Benzinga · Oct 10, 2023
Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Gainers SuperCom Ltd. (NASDAQ: SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after falling 13% on Monday. Immunic, Inc. (NASDAQ: IMUX) shares gained 13.2% to $1.80 in pre-market trading after the company disclosed positive interim data from Phase 2 CALLIPER trial of vidofludimus calcium in progressive multiple sclerosis. Tempest Therapeutics, Inc. (NASDAQ: TPST) shares rose 21.1% to $0.2785 in pre-market trading, after falling 8% on Monday. Mobilicom Limited (NASDAQ: MOB) rose 41.1% to $2.05 in pre-market trading, after gaining more than 11% on Monday. SMX (Security Matters) Public Limited Company (NASDAQ: SMX) shares climbed 18.2% to $2.01 in pre-market trading, after jumping 18% on Monday. Domaine Des Massifs and SMX recently formed a strategic collaboration to revolutionize traceability. ContraFect Corporation (NASDAQ: CFRX) rose 16.8% to $0.5277 in pre-market trading, after surging more than 12% on Monday. ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 13.8% to $3.07 in pre-market trading. ParaZero Technologies shares jumped 133% on Monday ...
Benzinga · Oct 10, 2023
Immunic's (IMUX) Ulcerative Colitis Study Shows Positive Data
Immunic (IMUX) reports positive results from the maintenance phase of the phase II study evaluating its lead candidate, vidofludimus calcium, to treat patients with ulcerative colitis.
Zacks Investment Research · Apr 6, 2023
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite Delivery/Indefinite Quantity contract for high energy laser beams. Liminal BioSciences Inc. (NASDAQ: LMNL) gained 73.3% to $6.55 after Thomvest submitted an unsolicited non-binding transaction proposal to acquire Liminal on an all cash basis. InflaRx N.V. (NASDAQ: IFRX) shares climbed 49.8% to $5.65 on continued upward momentum after the company yesterday announced it received FDA EUA for Gohibic for the treatment of critically ill COVID-19 patients. Today, LifeSci Capital upgraded the stock from Market Perform to Outperform. Freight Technologies, Inc. (NASDAQ: FRGT) gained 35% to $2.31 after the company reported the highest monthly increase in new clients since Fr8App's platform inception. Also, the company expects 2023 revenue guidance of $36 million, representing a nearly 40% growth from Fr8App's 2022 full-year revenue. YS Biopharma Co., Ltd. (NASDAQ: YS) jumped 23.3% to $1.90. YS Biopharma recently announced interim Phase 2 safety and immunogenicity data for its PIKA recombinant Covid-19 vaccine. 180 Life Sciences Corp. (NASDAQ: ATNF) gained 23% to $2.19. SenesTech, Inc. (NASDAQ: SNES) gained 22% to $1.88 after the company announced it signed a distribution agreement with Target Specialty Products for ContraPest. Immunic, Inc. (NASDAQ: IMUX) jumped 20.8% to $1.7650 after the company reported data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset, vidofludimus calcium (IMU-838), in patients with moderate-to-severe ulcerative colitis. Bit Origin Ltd (NASDAQ: BTOG) surged 20.8% to $0.29. TransCode Therapeutics, Inc. (NASDAQ: RNAZ) surged 19.1% to $0.3931 after the company announced that it has been awarded the third year of a Fast-Track Small Business Innovation Research grant from the NIH to support the clinical evaluation of TTX-MC138. a.k.a. Brands Holding Corp. (NYSE:
Benzinga · Apr 5, 2023
Best Penny Stocks For 2023? 3 To Watch In March
Hot penny stocks to watch now. The post Best Penny Stocks For 2023? 3 To Watch In March appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks · Mar 6, 2023
BARK And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones closed higher by more than 150 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.3 BARK The Trade: BARK, Inc. (NYSE: BARK) Executive Chairman Matt Meeker bought a total of 14,950 shares at an average price of $1.69. To acquire these ...
Benzinga · Nov 28, 2022
Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday. Altamira Therapeutics Ltd. (NASDAQ: CYTO) climbed 58.6% to close at $0.5197 on Friday after the company announced divestiture of its inner ear development assets. Missfresh Limited (NASDAQ: MF) gained 57.5% to close at $2.52. Enservco Corporation (NYSE: ENSV) climbed 37.4% to close at $2.02. Kaleyra, Inc. (NYSE: KLR) gained 24.9% to close at $0.8616. Veris Residential, Inc. (NYSE: VRE) surged 23.3% to close at $15.31 after Kushner Companies made an offer to acquire the company for $16 per share. Matinas BioPharma Holdings, Inc. (NYSE: MTNB) rose 22.2% to settle at $0.8538. Matinas BioPharma announced interim data from the Phase 2 EnACT trial of MAT2203 for the treatment of cryptococcal meningitis, exceeding primary endpoint threshold. Candel Therapeutics, Inc. (NASDAQ: CADL) gained 21.6% to close at $1.80. Energy Focus, Inc (NASDAQ: EFOI) shares climbed 21.5% to close at $0.4900. Energy Focus, last month, named Lesley Matt as CEO. Leju Holdings Limited (NYSE: LEJU) gained 21.1% to settle at $1.61. Rail Vision Ltd. (NASDAQ: RVSN) gained 20.5% to close at $0.5898. Rockley Photonics Holdings Limited (NYSE: RKLY) surged 20.1% to settle at $0.6262. The Boston Beer Company, Inc. (NYSE: SAM) jumped 19.7% to close at $402.28 after the company reported better-than-expected Q3 adjusted EPS and sales results. MacroGenics, Inc. (NASDAQ: MGNX) rose 19.4% to close at $4.80. TuanChe Limited (NASDAQ: TC) climbed 19.1% to settle at $7.87. Zentek Ltd. (NASDAQ: ZTEK) gained 18.9% to close at $1.57. Yunji Inc. (NASDAQ: YJ) rose 18.6% to close at $1.02. Snow Lake Resources Ltd. (NASDAQ: LITM) climbed 18.5% to close at $2.43. Biohaven Ltd. (NYSE: BHVN) gained 17.7% to close at $14.08. Biohaven reported pricing of public offering of 25 million common shares at a price of $10.50 per share. Amprius Technologies, Inc. (NASDAQ: AMPX) climbed 17.6% to close at $11.11. Amprius Technologies was awarded a $50 million cost-sharing grant from the U.S. Department of Energy's Office of Manufacturing and Energy Supply Chains. Healthcare Triangle, Inc. (NASDAQ: HCTI) gained 17.2% to close at $0.3875. AppTech Payments Corp. (NASDAQ: APCX) gained 16.4% to settle at $0.8849. Pacific Biosciences of California, Inc. (NASDAQ: PACB) climbed 16.3% to close at $7.77. Biotricity, Inc. (NASDAQ: BTCY) rose 15.7% to close at $1.10. uCloudlink Group Inc. (NASDAQ: ...
Benzinga · Oct 24, 2022
Analyst Downgrades Immunic After Lack of Details Drive Uncertainty
SVB Leerink has downgraded Immunic Inc (NASDAQ: IMUX) to Market Perform from Outperform following disappointing initial data from the highly anticipated Phase 1b proof-of-concept study for IMU-935 in patients with moderate-to-severe psoriasis. The analyst lowered the price target to $5 from $9. "While we appreciate that this is an interim readout in which many study aspects are still blinded, we believe ...Full story available on Benzinga.com
Benzinga · Oct 21, 2022
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
IM
IMUX
Immunic, Inc. Common Stock
Buy
Sell
Market
Limit
Soon
IMUX
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any IMUX yet.
Related Tickers
Earnings